Posts

Showing posts with the label AI Stocks

Defense Gets a Glow-Up: How Trump’s Golden Dome Could Light Up Your Portfolio

Image
    Donald Trump’s “Golden Dome” missile shield isn’t just a leap in defense—it’s a spark for a new stock market arms race. As the U.S. gears up for the world’s most advanced AI-driven missile defense, which companies stand to cash in, what exactly do they bring to the table, and why should investors care? Here’s your field guide to the companies that could define America’s next defense boom.   L3Harris Technologies (NYSE: LHX) What They Do: L3Harris is a heavyweight in advanced communications, space-based sensors, and defense electronics. The company builds everything from high-tech radios for the military to sophisticated satellite tracking systems. Golden Dome Role: Expect L3Harris to provide the “eyes” of the Golden Dome—satellites, sensors, and tracking gear that spot threats in real time. With recent investments in its Indiana space facility, L3Harris is positioning itself at the heart of the Dome’s surveillance backbone. Why Consider It: L3Harris isn...

Investment Thesis: CoreWeave is a Risky and Overhyped Bet in the AI Cloud Boom

Image
The AI boom has unleashed a frenzy of investment in cloud infrastructure, with CoreWeave emerging as one of its most controversial players. Positioned as a specialized GPU cloud provider, the company has ridden the wave of demand for Nvidia’s cutting-edge chips, securing billion-dollar contracts with tech giants like Microsoft. Yet beneath its meteoric revenue growth lies a business model riddled with red flags: extreme customer concentration, crushing debt loads, and existential dependence on Nvidia’s supply chain. From its tepid IPO to its negative interest coverage ratio, the numbers paint a cautionary tale. While the AI revolution has rewarded aggressive infrastructure bets, CoreWeave’s survival hinges on factors beyond its control: Nvidia’s pricing power, Microsoft’s spending whims, and its ability to outspend deep-pocketed rivals. For investors, the central question isn’t just whether AI demand will persist—but whether CoreWeave can escape its debt trap before the hype fades. ...

Is Nvidia Playing 4D Chess with Its Earnings, or Just Delaying the Inevitable?

Image
As Nvidia (NASDAQ: NVDA) prepares to drop its highly anticipated earnings report at the end of February 2025 , sharp-eyed analysts have noticed something interesting: a series of recent strategic divestments . The AI and semiconductor giant has offloaded stakes in SoundHound AI (NASDAQ: SOUN) and Serve Robotics , while also trimming its position in Arm Holdings (NASDAQ: ARM) .                The big question: Is Nvidia tightening its books ahead of earnings to paint a glowing financial picture? Or is it just stalling the inevitable disappointment when expectations outpace reality? Cashing Out Big on AI Winners—But Will It Be Enough? Let’s break it down. Nvidia made well-timed bets on SoundHound AI and Serve Robotics early in 2024, just before these stocks soared. SoundHound AI, for example, skyrocketed over 120% year-to-date , making it an incredibly lucrative exit for Nvidia. By selling at the peak, Nvidia likely booked millions in profit , padd...

The Silent Kingmaker of AI: How ASML Holds the Keys to the Chip Kingdom

Image
    In the high-stakes race to dominate AI hardware, all eyes are on NVIDIA, AMD, and Intel. But while these tech titans battle for market share, there’s an unsung hero in the background pulling the real strings—ASML. As the sole producer of Extreme Ultraviolet (EUV) lithography machines, ASML ( https://www.asml.com/en ) is the true gatekeeper of the semiconductor industry. Without its cutting-edge machines, even the most advanced chip designs remain just that—designs. And now, with the arrival of the next-gen TWINSCAN EXE:5000 (High-NA) EUV machines , the balance of power in AI chip manufacturing could be shifting. Now having a view who all possess these machines.   Intel Corporation TWINSCAN EXE:5000 (High-NA) Taiwan Semiconductor Manufacturing Company (TSMC) TWINSCAN EXE:5000 (High-NA) Samsung Electronics TWINSCAN EXE:5000 (High-NA)   This surely places Intel in the forefront for ...

Nvidia Drops 17%: Is DeepSeek’s AI the Catalyst, or Is Wall Street Masking a Bigger Problem?

Image
  When Nvidia’s stock nosedived by 17% on January 27, 2025, the market quickly pointed fingers at DeepSeek, a Chinese AI startup that unveiled a groundbreaking model on January 20. But was DeepSeek’s announcement the real culprit, or are we witnessing a classic market play—using a convenient narrative to mask something much larger? Nvidia Price end of January 20, 2025: 140 approx   DeepSeek model was released on January 20,2025   Nvidia Price end of January 20, 2025: 140 approx   Trump announced Project Stargate on January 22, 2025        Nvidia Price end of January 22, 2025: 147 approx     Markets reacted on January 27, 2025, and Nvidia slides down by 17%   Nvidia Price end of January 27, 2025: 118.58   So the price since the announcement by DeepSeek from 20 th January to 24 th January the price either rose or kind of stayed same level –   Now the benchmarks were released by Deepseek on January 20 th , 20...

Don’t Chase AI Drug Gold—Invest in the Shovel Suppliers Instead!

Image
The race to revolutionize healthcare through AI-driven drug discovery has captured the world's imagination, with countless startups and biotech firms making headlines for their cutting-edge approaches.  With the AI performing the custom drug discoveries, Larry Ellison creating the big hype with the announce of the new Project Stargate.  While these companies promise breakthroughs, the real opportunity may lie elsewhere—investing in the backbone of this revolution. Just as the gold rush rewarded those who sold shovels, the AI drug discovery boom is creating immense demand for tools, infrastructure, and expertise that power these innovations. From high-performance computing and automation systems to cloud platforms and bioinformatics tools, the providers of these essential technologies stand to reap the rewards of this rapidly growing industry. Let’s dive into why these unsung heroes might just be the smartest investment in the AI healthcare gold rush. So lets put together the n...